✦ LIBER ✦

RGD-Modified PEG-PAMAM-DOX Conjugate: In Vitro and In Vivo Targeting to Both Tumor Neovascular Endothelial Cells and Tumor Cells

✍ Scribed by Saijie Zhu; Lili Qian; Minghuang Hong; Lihong Zhang; Yuanying Pei; Yanyan Jiang

Book ID: 102690392
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 580 KB
Volume: 23
Category: Article
ISSN: 0935-9648
DOI: 10.1002/adma.201003944

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

miR-135a contributes to paclitaxel resis

miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo

✍ Holleman, A; Chung, I; Olsen, R R; Kwak, B; Mizokami, A; Saijo, N; Parissenti, A 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 842 KB

Addition of both platelets and thrombin

Addition of both platelets and thrombin in combination accelerates tumor cells to adhere to endothelial cellsIn vitro

✍ Ingrid B. Helland; Beate Klementsen; Leif Jørgensen 📂 Article 📅 1997 🏛 Society for In Vitro Biology 🌐 English ⚖ 553 KB

Shb Gene Knockdown Increases the Suscept

Shb Gene Knockdown Increases the Susceptibility of SVR Endothelial Tumor Cells to Apoptotic Stimuli In Vitro and In Vivo

✍ Funa, Nina S; Reddy, Kalpana; Bhandarkar, Sulochana; Kurenova, Elena V; Yang, Li 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 1005 KB

Selective antibody-mediated targeting of

Selective antibody-mediated targeting of class I MHC to EGFR-expressing tumor cells induces potent antitumor CTL activity in vitro and in vivo

✍ Hila Novak; Roy Noy; Kfir Oved; Dina Segal; Winfried S. Wels; Yoram Reiter 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 276 KB 👁 1 views

## Abstract Epidermal growth factor receptor (EGFR) is highly overexpressed in many tumor types. We present a new fusion molecule that can target solid tumors that express EGFR. The fusion molecule combines the advantage(s) of the well‐established tumor targeting capabilities of high affinity recom

Effect of IFN-γ treatment and in vivo pa

Effect of IFN-γ treatment and in vivo passage of murine tumor cell lines on their sensitivity to lymphokine-activated killef (LAK) cell lysis in vitro; association with H-2 expression on the target cells

✍ Li Tsai; Claes Öhlén; Hans-Gustaf Ljunggren; Klas Kärre; Mona Hansson; Rolf Kies 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 555 KB

Interferon-gamma (IFN-y) treatment or in vivo passage of the murine YAC-I lymphoma resulted in reduced sensitivity to in vitro lysis by syngeneic murine spleen cells cultured in rll-2 (LAK-cells). IFN-y treatment also rendered the murine B16 melanoma less sensitive to lysis by syngeneic LAK cells, w